Oramed Pharmaceuticals Inc. - stock earnings
ORMP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -8.5 million USD | 681000 USD |
| 2022Q3 | -7.1 million USD | 682000 USD |
| 2022Q2 | -10.5 million USD | 674000 USD |
| 2022Q1 | -10.4 million USD | 666000 USD |
| 2021Q4 | -7.9 million USD | 674000 USD |
| 2021Q3 | -6.9 million USD | 683000 USD |
| 2021Q2 | -5.2 million USD | 681000 USD |
| 2021Q1 | -4.6 million USD | 665000 USD |
| 2020Q4 | -5.6 million USD | 674000 USD |
| 2020Q3 | -3.0 million USD | 681000 USD |
ORMP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.8 million USD | 2.7 million USD |
| 2022 | -36.6 million USD | 2.7 million USD |
| 2021 | -22.2 million USD | 2.7 million USD |
| 2020 | -11.5 million USD | 2.7 million USD |
| 2019 | -14.4 million USD | 2.7 million USD |
| 2018 | -12.7 million USD | 2.4 million USD |
| 2017 | -10.5 million USD | 2.5 million USD |
| 2016 | -11.0 million USD | 641000 USD |
| 2015 | -7.2 million USD | ? USD |
| 2014 | -5.7 million USD | ? USD |
| 2013 | -4.2 million USD | ? USD |
| 2012 | -3.3 million USD | 184254 USD |
| 2011 | -1.6 million USD | 197412 USD |
| 2010 | -3.0 million USD | ? USD |
| 2009 | -2.8 million USD | ? USD |
| 2008 | -2.8 million USD | ? USD |
| 2007 | -3.2 million USD | ? USD |
| 2006 | -414576 USD | ? USD |
| 2005 | -720000 USD | ? USD |
| 2004 | -720000 USD | ? USD |
| 2003 | -50000 USD | ? USD |
ORMP
Price: $2.34
52 week price:
Earnings Per Share: 0.14 USD
P/E Ratio: -6.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Ebitda: -2.5 millionMarket Capitalization: 99.3 million